Shattuck Labs (STTK) announced the appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors, effective March 1, 2024. Both Dr. Siegall and Dr. Sasser are highly successful executives and scientific pioneers who bring valuable industry experience to Shattuck. Dr. Clay Siegall is the President, Chief Executive Officer and Chairman of the Board of Immunome (IMNM). Dr. Kate Sasser is the Chief Scientific Officer of Tempus.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on STTK:
- Shattuck Labs reports Q4 EPS (41c), consensus (57c)
- Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
- Shattuck Labs Announces Participation in Upcoming March Conferences
- Ono enters drug discovery pact, option agreement with Shattuck Labs
- 3 Best Stocks to Buy Now, 2/14/2024, According to Top Analysts